Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03342911
Title Nivolumab, Carboplatin, and Paclitaxel in Treating Patients With Stage III-IV Head and Neck Squamous Cell Carcinoma That Can Be Removed by Surgery
Recruitment Suspended
Gender both
Phase Phase II
Variant Requirements No
Sponsors Sidney Kimmel Cancer Center at Thomas Jefferson University

oropharynx cancer

head and neck squamous cell carcinoma

oral squamous cell carcinoma

hypopharynx cancer

laryngeal squamous cell carcinoma


Carboplatin + Nivolumab + Paclitaxel

Age Groups: senior | adult
Covered Countries USA

No variant requirements are available.